These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 1651310

  • 1. Halogenated pyrimidines as radiosensitizers for high grade glioma: revisited.
    Rodriguez R, Kinsella TJ.
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):859-62; discussion 865. PubMed ID: 1651310
    [No Abstract] [Full Text] [Related]

  • 2. [Significance of the combined use of radiosensitizing agents on radiotherapy of malignant encephaloma].
    Hoshino T.
    Rinsho Hoshasen; 1968 Nov; 13(11):885-91. PubMed ID: 4304555
    [No Abstract] [Full Text] [Related]

  • 3. Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme.
    Jackson D, Kinsella T, Rowland J, Wright D, Katz D, Main D, Collins J, Kornblith P, Glatstein E.
    Am J Clin Oncol; 1987 Oct; 10(5):437-43. PubMed ID: 2821790
    [Abstract] [Full Text] [Related]

  • 4. Tumour radiosensitization with the halogenated pyrimidines 5'-bromo- and 5'-iododeoxyuridine.
    Epstein AH, Cook JA, Goffman T, Glatstein E.
    BJR Suppl; 1992 Oct; 24():209-14. PubMed ID: 1290703
    [No Abstract] [Full Text] [Related]

  • 5. Editorial: Hypoxic cell radiosensitizers.
    Belli JA, Hellman S.
    N Engl J Med; 1976 Jun 17; 294(25):1399-400. PubMed ID: 177876
    [No Abstract] [Full Text] [Related]

  • 6. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
    Prados MD, Scott CB, Rotman M, Rubin P, Murray K, Sause W, Asbell S, Comis R, Curran W, Nelson J, Davis RL, Levin VA, Lamborn K, Phillips TL.
    Int J Radiat Oncol Biol Phys; 1998 Feb 01; 40(3):653-9. PubMed ID: 9486616
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of bromodeoxyuridine in glioblastoma multiforme: a Northern California Cancer Center Phase II study.
    Phillips TL, Levin VA, Ahn DK, Gutin PH, Davis RL, Wilson CB, Prados MD, Wara WM, Flam MS.
    Int J Radiat Oncol Biol Phys; 1991 Aug 01; 21(3):709-14. PubMed ID: 1651306
    [Abstract] [Full Text] [Related]

  • 8. [Results of postoperative treatment of glioblastoma multiforme with a radiation-sensitizing substance (5-bromo-2-deoxyuridine)].
    Landolt AM.
    Acta Neurochir (Wien); 1971 Aug 01; 24(4):263-8. PubMed ID: 4332090
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Radiation plus metronidazole for glioblastoma.
    Urtasun RC, Band PR, Chapman JD, Feldstein ML.
    N Engl J Med; 1977 Mar 31; 296(13):757. PubMed ID: 190541
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A Phase I study of intermittent intravenous bromodeoxyuridine (BUdR) with conventional fractionated irradiation.
    Kinsella TJ, Russo A, Mitchell JB, Rowland J, Jenkins J, Schwade J, Myers CE, Collins JM, Speyer J, Kornblith P.
    Int J Radiat Oncol Biol Phys; 1984 Jan 31; 10(1):69-76. PubMed ID: 6321412
    [Abstract] [Full Text] [Related]

  • 16. A phase II trial of high-dose bromodeoxyuridine with accelerated fractionation radiotherapy followed by procarbazine, lomustine, and vincristine for glioblastoma multiforme.
    Groves MD, Maor MH, Meyers C, Kyritsis AP, Jaeckle KA, Yung WK, Sawaya RE, Hess K, Bruner JM, Peterson P, Levin VA.
    Int J Radiat Oncol Biol Phys; 1999 Aug 01; 45(1):127-35. PubMed ID: 10477016
    [Abstract] [Full Text] [Related]

  • 17. Radiosensitization of brain tumor cells with a thymidine analogue (bromouridine).
    Sano K, Hoshino T, Nagai M.
    J Neurosurg; 1968 Jun 01; 28(6):530-8. PubMed ID: 4233585
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Accelerated radiotherapy with carbogen and nicotinamide (ARCON) in high grade malignant gliomas.
    Lambin P, Poortmans P, Menten J, Hamers HP.
    Radiother Oncol; 1997 Jun 01; 43(3):324. PubMed ID: 9215796
    [No Abstract] [Full Text] [Related]

  • 20. Radiobiology and clinical application of halogenated pyrimidine radiosensitizers.
    Mitchell JB, Russo A, Cook JA, Straus KL, Glatstein E.
    Int J Radiat Biol; 1989 Nov 01; 56(5):827-36. PubMed ID: 2573682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.